Thirty-five weeks. Fifth pregnancy, fourth living child. She is on the antepartum unit for evaluation of an amniotic-fluid-index discrepancy — the initial scan had been low, the repeat the next morning had been normal, and we are working through whether what we are seeing is measurement variability, occult rupture of membranes, or the early signal of placental insufficiency. Her chronic hypertension is being managed on her home regimen. Her cystocele — a bladder prolapse that began at twelve weeks of this pregnancy and that has been symptomatic since then with the visible tissue at the introitus and the pelvic pressure she has been carrying for six months — is the surgical referral I am about to give her for after the delivery.
Her four children are at home with her twenty-year-old son and her elderly mother. Her partner situation is, in her words, "complicated." She is anxious in a way that has been clinically loud since the moment we walked in — her shoulders up, her hands fidgeting, her breath shallow. She has not been on anti-anxiety medication. She has declined it in the past. She is, today, open to reconsidering.
This is a multiparous patient at thirty-five weeks with three concurrent clinical problems and four children at home, presenting on Medicaid coverage that, until 2021, expired sixty days postpartum and that, under the American Rescue Plan Act extension that forty-eight states adopted between 2021 and 2024, currently extends to twelve months postpartum. The twelve-month extension was the federal policy change that, in operational terms, made the post-delivery clinical plan I am about to give her possible. The cystocele surgical repair — an anterior colporrhaphy performed by a urogynecologist — needs to be scheduled approximately three to six months postpartum, after the tissue has had time to heal and the patient has returned to her pre-pregnancy hormonal baseline. The chronic hypertension management requires ongoing monthly visits and antihypertensive medication coverage. The anxiety management, if she accepts the SSRI trial we discussed this morning, requires a prescription she can fill and a follow-up that the SSRI's clinical trajectory needs to be measured against. All of these are Medicaid-covered services. All of them depend on the twelve-month postpartum extension being operational at the date the patient needs them.
The OBBBA Medicaid cuts that take effect in January 2027 will, on CBO scoring, produce procedural disenrollment of approximately five million Medicaid beneficiaries through paperwork failures rather than through actual ineligibility. The work-requirements provision will fall hardest on patients whose lives — five children, complicated partner, eldercare responsibility, intermittent housing, financial instability — make documentation of the eighty hours of monthly work-equivalent activity, in the formats the state-Medicaid bureaucracy requires, operationally impossible to maintain across a full year. The patient I am consenting today for a postpartum surgical referral is, by the strict CBO projection, in the population most likely to lose her coverage between the time we are having this conversation and the time the surgery she needs is scheduled. The federal-policy decision that disenrolls her is the decision that converts the surgical plan I am writing into a paper that she cannot operationally use.
I do not say this to her. The bedside is not the place for a federal-policy briefing. What I say is the clinical plan: discharge home today with strict return precautions, follow-up Wednesday for the third AFI ultrasound, delivery anticipated at approximately thirty-six weeks if the AFI returns low, postpartum urogynecology referral that the discharge planner will arrange, antihypertensive management to continue on home regimen, and an SSRI trial to be discussed with her outpatient obstetrician at the postpartum visit. The plan is the plan that the clinical evidence base supports. The plan also presumes a Medicaid coverage architecture that, in the post-OBBBA environment, is no longer something the plan can presume.
I can do the plan. I can write the discharge summary in language that makes the coverage-window dependence visible to whatever clinician sees her in two months, four months, six months, ten months. I can list, in the postpartum-plan section of the discharge summary, the specific services — urogynecology surgical referral, antihypertensive management, SSRI initiation, well-woman follow-up — whose feasibility depends on her Medicaid coverage remaining active through the twelve-month postpartum window. I can flag her in the practice's care-management system so that the social worker who follows our high-risk postpartum patients reaches out monthly with renewal documentation reminders. I can write the same documentation, in the same form, for every other patient like her this week, knowing that the cumulative effect of the documentation is — in the operational reality of a federal policy that converts paperwork into the disenrollment mechanism — only marginally protective.
What I cannot do, from her bedside, is fix the policy environment that has, between her last delivery and this one, converted the twelve-month postpartum Medicaid extension from an established federal coverage commitment into a policy provision that the OBBBA framework is, by design, putting pressure on. The patient who comes through my office in 2030 — her sixth pregnancy or her cousin's first — will be operating inside the Medicaid coverage architecture that the 2027 work-requirements provision produces. The surgical referral I am writing today is the surgical referral the patient in 2030 may not be able to use.
When the medicine has limits, the care does not. The care, this week, was the plan I wrote with the assumption the coverage architecture still allows. The work — the work that does not happen at the bedside — is making sure the coverage architecture is still there when she needs it.
DICT-00038 (de-identified).